FTC’s case against CVS, Cigna, and UnitedHealth’s PBMs is ... Several state and local governments also filed lawsuits against drug companies and pharmacy benefit managers, accusing them ...

The FTC on Tuesday paused its in-house case against CVS Health’s CVS Caremark ... decision to file an amicus brief in a class-action lawsuit against PBMs, he wrote Thursday in a statement ...

FTC General ... The pause will remain in effect for at least 105 days, and an evidentiary hearing date will be scheduled 225 days after the stay is lifted, the order says. CVS Health, Cigna ...

This week, the Federal Trade Commission halted its lawsuit against pharmacy-benefit managers CVS Caremark (CVS), Express ... The agency said it needs to pause the litigation because no current ...

The lawsuit ... are owned by CVS, Cigna and UnitedHealth, respectively — of artificially inflating the cost of insulin, driving up prices for payers and patients. However, the FTC’s general ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, CVS Health ... the FTC’s earlier decision to pause the case ...

The FTC said it needs to pause the litigation ... s Optum Rx and CVS Health’s CVS Caremark, accusing the firms of inflating the price of insulin. The lawsuit said firms profited by pocketing ...

Chairman of the Federal Trade Commission Andrew Ferguson says he plans to resume a lawsuit alleging that the ... Ferguson added that he consulted the FTC’s ethics attorneys before arriving ...

(Reuters) - The U.S. Federal Trade Commission's lawsuit ... with FTC ethics officials and decided to unrecuse himself so the case against UnitedHealth Group's Optum unit, CVS Health's CVS Caremark ...

Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against ... drug middlemen. The FTC paused the litigation against CVS’ Caremark, Cigna ...